170 related articles for article (PubMed ID: 7838013)
1. Bronchodilators: beta-agonists.
Goldie RG; Lulich KM; Paterson JW
Med J Aust; 1995 Jan; 162(2):100-2. PubMed ID: 7838013
[No Abstract] [Full Text] [Related]
2. [New viewpoints on therapy with beta-2-agonist-type bronchodilators and corticosteroids in bronchial asthma].
Ionescu AA
Pneumoftiziologia; 1992; 41(4):257-8. PubMed ID: 1364071
[No Abstract] [Full Text] [Related]
3. [Agonists of the beta adrenergic receptors of the bronchial tree].
Pacheco CR
Gac Med Mex; 1981 Dec; 117(12):474-5. PubMed ID: 6123461
[No Abstract] [Full Text] [Related]
4. [The beta-2-agonists in asthma in infants and young children].
Dubus JC; Mély L; Stremler-Lebel N; Chabrol B
Arch Pediatr; 2002 Aug; 9 Suppl 3():384s-389s. PubMed ID: 12205813
[TBL] [Abstract][Full Text] [Related]
5. Bronchodilators in asthma.
Robertson C; Levison H
Chest; 1985 Jan; 87(1 Suppl):64S-68S. PubMed ID: 2856868
[No Abstract] [Full Text] [Related]
6. [Beta 2-sympathomimetic drugs].
Criée CP; Laier-Groeneveld G
Internist (Berl); 1995 Sep; 36(9):918-23. PubMed ID: 7591618
[No Abstract] [Full Text] [Related]
7. Beta-adrenergic bronchodilators.
Nelson HS
N Engl J Med; 1995 Aug; 333(8):499-506. PubMed ID: 7623883
[No Abstract] [Full Text] [Related]
8. Does use or withdrawal of long-acting beta 2-adrenoceptor induce desensitisation?
Molimard M; Moore N; Begaud B
Lancet; 1998 Jan; 351(9095):66-7. PubMed ID: 9433446
[No Abstract] [Full Text] [Related]
9. [Beta-2 agonists].
Devillier P
Rev Mal Respir; 1998 Sep; 15 Suppl 2():S45-50. PubMed ID: 9809344
[No Abstract] [Full Text] [Related]
10. Long acting beta2 agonists: are they safe?
Wijesiriwardena B
Ceylon Med J; 2006 Dec; 51(4):129-31. PubMed ID: 17461321
[No Abstract] [Full Text] [Related]
11. Continuous eformoterol and beta 2-receptor responsiveness.
Sussman HS
Br J Clin Pract Suppl; 1995 Sep; 81():16-7. PubMed ID: 8546889
[No Abstract] [Full Text] [Related]
12. The physiological approach to the management of asthma. I. Introduction to adrenergic bronchodilators.
Dwyer JM
Ann Allergy; 1981 Nov; 47(5 Pt 2):375-8. PubMed ID: 6118082
[No Abstract] [Full Text] [Related]
13. Long- versus short-acting beta 2-agonists. Implications for drug therapy.
Boulet LP
Drugs; 1994 Feb; 47(2):207-22. PubMed ID: 7512898
[No Abstract] [Full Text] [Related]
14. Long-acting bronchodilators for the control of asthma symptoms.
Marshall GD
Ann Allergy Asthma Immunol; 2001 Jan; 86(1):3-4. PubMed ID: 11206235
[No Abstract] [Full Text] [Related]
15. [Update on beta-adrenergic agonists and corticosteroid aerosols].
Spector S
Rev Alerg Mex; 1993; 40(6):i-iv. PubMed ID: 9296815
[No Abstract] [Full Text] [Related]
16. Formoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease.
Prenner BM
Expert Opin Pharmacother; 2007 Dec; 8(17):3069-84. PubMed ID: 18001266
[TBL] [Abstract][Full Text] [Related]
17. [Current bronchodilator strategies in the treatment of asthma].
Aubier M
Rev Med Interne; 1994; 15 Suppl 2():240s-244s. PubMed ID: 7915852
[TBL] [Abstract][Full Text] [Related]
18. [Beta-adrenergic agents in asthma].
Morales AM; Osuna LA; Javier RC; Suárez FN; Aldana IO
Rev Alerg Mex; 1996; 43(1):2-4. PubMed ID: 8901032
[No Abstract] [Full Text] [Related]
19. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
Kim D; Glaum M; Lockey R
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
[TBL] [Abstract][Full Text] [Related]
20. Filling in the gaps.
Roberts J
Nurs Stand; 2002 May 15-21; 16(35):27. PubMed ID: 12212333
[No Abstract] [Full Text] [Related]
[Next] [New Search]
